Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 2
1998 1
1999 2
2000 5
2001 3
2002 7
2003 6
2004 4
2005 9
2006 6
2007 7
2008 3
2009 2
2010 3
2012 4
2013 4
2014 6
2015 5
2016 7
2017 10
2018 9
2019 7
2020 6
2021 8
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Lehrnbecher T, Robinson PD, Ammann RA, Fisher B, Patel P, Phillips R, Beauchemin MP, Carlesse F, Castagnola E, Davis BL, Elgarten CW, Groll AH, Haeusler GM, Koenig C, Santolaya ME, Tissing WJE, Wolf J, Alexander S, Hu H, Dupuis LL, Sung L. Lehrnbecher T, et al. J Clin Oncol. 2023 Mar 20;41(9):1774-1785. doi: 10.1200/JCO.22.02224. Epub 2023 Jan 23. J Clin Oncol. 2023. PMID: 36689694 Free PMC article.
Changes from the 2017 CPG included two conditional recommendations regarding (1) discontinuation of empiric antibacterial therapy in clinically well and afebrile patients with low-risk FN if blood cultures remain negative at 48 hours despite no evidenc …
Changes from the 2017 CPG included two conditional recommendations regarding (1) discontinuation of empiric antibacterial therapy in …
[Febrile neutropenia in cancer patients: management in the emergency room].
Rivera-Salgado D, Valverde-Muñoz K, Ávila-Agüero ML. Rivera-Salgado D, et al. Rev Chilena Infectol. 2018;35(1):62-71. doi: 10.4067/s0716-10182018000100062. Rev Chilena Infectol. 2018. PMID: 29652973 Free article. Review. Spanish.
Patients with febrile neutropenia have a much greater risk of developing bacterial disease, and fever may be the only indicator of severe bacterial infection. Adequate management of febrile neutropenia emphasizes early recognition of p …
Patients with febrile neutropenia have a much greater risk of developing bacterial disease, and fever may be the …
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L. Lehrnbecher T, et al. J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1. J Clin Oncol. 2017. PMID: 28459614 Review.
Methods The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group of experts in pediatric oncology and infectious diseases that includes a patient advocate. ...Key differences from our 2012 FN CPG included the l …
Methods The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group of experts i …
Risk assessment and treatment of low-risk patients with febrile neutropenia.
Kern WV. Kern WV. Clin Infect Dis. 2006 Feb 15;42(4):533-40. doi: 10.1086/499352. Epub 2006 Jan 6. Clin Infect Dis. 2006. PMID: 16421798 Review.
Clinical criteria, such as comorbidities and performance status, remain critical in the risk-assessment process and probably are used by most physicians caring for patients with cancer who are febrile and neutropenic. ...If the appropriate infrastructu …
Clinical criteria, such as comorbidities and performance status, remain critical in the risk-assessment process and probably a …
Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia.
Fontanella C, Bolzonello S, Lederer B, Aprile G. Fontanella C, et al. Breast Care (Basel). 2014 Apr;9(4):239-45. doi: 10.1159/000366466. Breast Care (Basel). 2014. PMID: 25404882 Free PMC article. Review.
Neutropenic cancer patients may develop febrile neutropenia and CIN-related severe medical complications. Specific risk assessment scores, along with comprehensive clinical evaluation, are able to define a group of febrile patients …
Neutropenic cancer patients may develop febrile neutropenia and CIN-related severe medical complications. Specific r …
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J. Klastersky J, et al. J Clin Oncol. 2000 Aug;18(16):3038-51. doi: 10.1200/JCO.2000.18.16.3038. J Clin Oncol. 2000. PMID: 10944139
PURPOSE: Febrile neutropenia remains a potentially life-threatening complication of anticancer chemotherapy, but some patients are at low risk for serious medical complications. ...CONCLUSION: The risk index accurately identifies patie …
PURPOSE: Febrile neutropenia remains a potentially life-threatening complication of anticancer chemotherapy, but some patie …
Evaluating the accuracy and efficacy of an electronic medical record alert to identify paediatric patients with low-risk febrile neutropenia.
Corrente C, Satkumaran S, Segal A, Butters C, Fernandez C, Babl FE, Orme LM, Thursky K, Haeusler GM. Corrente C, et al. Int J Med Inform. 2023 Oct;178:105205. doi: 10.1016/j.ijmedinf.2023.105205. Epub 2023 Aug 30. Int J Med Inform. 2023. PMID: 37703799
BACKGROUND: Point-of-care decision support, embedded into electronic medical record (EMR) workflows, has the potential to improve efficiency, reduce unwarranted variation and improve patient outcomes. A clinical-facing best practice advisory (BPA) in the Epic EMR system wa …
BACKGROUND: Point-of-care decision support, embedded into electronic medical record (EMR) workflows, has the potential to improve efficiency …
Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review.
Pherwani N, Ghayad JM, Holle LM, Karpiuk EL. Pherwani N, et al. Am J Health Syst Pharm. 2015 Apr 15;72(8):619-31. doi: 10.2146/ajhp140194. Am J Health Syst Pharm. 2015. PMID: 25825185 Review.
PURPOSE: Strategies for the management of chemotherapy-induced febrile neutropenia (FN), including assessment tools for determining which patients are at low risk for FN complications and can be treated in the outpatient setting, are disc …
PURPOSE: Strategies for the management of chemotherapy-induced febrile neutropenia (FN), including assessment tools for …
Systematic review of reduced therapy regimens for children with low risk febrile neutropenia.
Morgan JE, Cleminson J, Atkin K, Stewart LA, Phillips RS. Morgan JE, et al. Support Care Cancer. 2016 Jun;24(6):2651-60. doi: 10.1007/s00520-016-3074-9. Epub 2016 Jan 13. Support Care Cancer. 2016. PMID: 26757936 Free article. Review.
PURPOSE: Reduced intensity therapy for children with low-risk febrile neutropenia may provide benefits to both patients and the health service. ...Randomised controlled trials (RCT) and prospective observational cohorts examining the loca …
PURPOSE: Reduced intensity therapy for children with low-risk febrile neutropenia may provide benefits to …
Advances in management of low-risk febrile neutropenia.
Teuffel O, Sung L. Teuffel O, et al. Curr Opin Pediatr. 2012 Feb;24(1):40-5. doi: 10.1097/MOP.0b013e32834c4b12. Curr Opin Pediatr. 2012. PMID: 22037219 Review.
PURPOSE OF REVIEW: To describe and discuss the most recent advances in the management of low-risk febrile neutropenia in children with cancer. RECENT FINDINGS: Several risk stratification tools for children with febrile neutropenia …
PURPOSE OF REVIEW: To describe and discuss the most recent advances in the management of low-risk febrile neutropeni …
120 results